Abstract:Abstract Abstract 4821 MiR-146a which is located on chromosomes 5 may be involved in normal hemtopoisis and the pathogenesis of several hematopoietic diseases through inhibiting the expression of its targets. Acute promyelocytic leukemia (APL) cell line NB4 was taken as research model to find out whether miR-146a expression was associated to cell differentiation and proliferation. The miR-146a expression level of NB4 cells decreased after ATRA treatment, meanwhile the expression level of its predicted target gene Smad4 increased simultaneously. MiR-146a expression plasmid, no related negative control sequence plasmid and recombined luciferase reporter gene vector containing the miR-146a complementary combined site on Smad4 plasmid were constructed by DNA recombination technical. Both recombined plasmids were transiently co-transfected into 293T cells with control plasmid pRL-TK. The interaction between miR-146a and its predicted target gene Smad4 was confirmed by the relative activities of dual luciferase detection. This interaction relationship was further confirmed by liposome entrapment transfection of miR-146a and its antisense molecular in NB4 cells. The expression level of miR-146a in NB4 cells did no influence on Smad4 gene expression but Smad4 protein expression levels (fig 1). The changes of NB4 cells on biological behaviors were observed by cell morphology, proliferation curve and flow cytometry methods under different miR-146a expression status. The results showed that cell proliferation ratio decreased and cell apoptosis ratio increased after miR-146a expression suppression in NB4 cells. The investigation of miR-146a expression levels in mononuclear cells of APL patients' bone marrow and clinical data were carried out. It was showed that the expression levels of miR-146a were higher in APL patients than normal controls. The expression level of miR-146a was positive correlated with peripheral blood white cell count (fig 2). MiR-146a expression level was negative correlated with Th/Ts ratio among these patients (fig 3). MiR-146a/Smad4 signal pathway is expressed in acute promyelocytic leukemia. The proliferation and apoptosis of the cells are modified by the Smad4 protein expression regulated by miR-146a expression. MiR-146a expression is somewhat associated with acknowledged clinical prognosis factors. It has potential possibility to take miR-146a as prognosis factor. Disclosures: No relevant conflicts of interest to declare.

[Mir-181A Promotes Proliferation of Human Acute Myeloid Leukemia Cells by Targeting ATM].

Mir-148A-3p Suppresses the Progression of Acute Myeloid Leukemia Via Targeting Cyclin-Dependent Kinase 6 (CDK6).

Mir-22 Has a Potent Anti-Tumour Role with Therapeutic Potential in Acute Myeloid Leukaemia

miR-550-1 functions as a tumor suppressor in acute myeloid leukemia via the hippo signaling pathway

MicroRNA-181a-mediated Downregulation of AC9 Protein Decreases Intracellular Camp Level and Inhibits ATRA-induced APL Cell Differentiation

Expression Characteristics and Prognosissignificance of Mirna-181A in Acute Myeloid Leukemia with Normal Karyotype

[Mir-18A Can Regulate Chemotherapy Sensitivity of Leukemia Cell HL-60 to VP-16 and VCR by Targeting ATM].

Mir-181A Post-Transcriptionally Downregulates Oncogenic RalA and Contributes to Growth Inhibition and Apoptosis in Chronic Myelogenous Leukemia (CML)

MicroRNA-181a Functions as an Oncomir in Gastric Cancer by Targeting the Tumour Suppressor Gene ATM

Mir-18A Expression Correlates with ATM and P53 Levels and Poor Prognosis in Lymphomas.

MiR-181a Down-Regulates PARP1 by Enhancing Its Acetylation in MLL -Rearranged AML

MiR-20a-5p Functions As a Potent Tumor Suppressor by Targeting PPP6C in Acute Myeloid Leukemia

Mir-181B Increases Drug Sensitivity in Acute Myeloid Leukemia Via Targeting HMGB1 and Mcl-1.

The Tumor Suppressive Role of Mirna-370 by Targeting FoxM1 in Acute Myeloid Leukemia.

Mir-146a Expression Level As A Molecular Marker In Acute Promyleocytic Leukemia

Long Non‑coding RNA MIR17HG Sponges Microrna‑21 to Upregulate PTEN and Regulate Homoharringtonine‑based Chemoresistance of Acute Myeloid Leukemia Cells

MiR-34a Promotes Apoptosis and Inhibits Autophagy by Targeting HMGB1 in Acute Myeloid Leukemia Cells

miR-603 promotes cell proliferation and differentiation by targeting TrkB in acute promyelocytic leukemia

MiR-204 Acts As a Potential Therapeutic Target in Acute Myeloid Leukemia by Increasing BIRC6-mediated Apoptosis.

Investigating the Microrna-Mrna Regulatory Network in Acute Myeloid Leukemia

Mir-18A Impairs DNA Damage Response Through Downregulation of Ataxia Telangiectasia Mutated (ATM) Kinase.